Pharmaceuticals, Biotechnology and Life Sciences
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that its Annual Report on Form…
Mylan and Lupin Limited have received from the European Commission (EC) marketing authorization for Nepexto, a biosimilar to Enbrel, for all indications of the reference product.
OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced the U.S. Food and Drug Administration…
Validation of Type II Variation will allow Takeda to commence launches in Europe later this year The pre-filled syringe presentation…
Seal of quality for outstanding corporate management Analysis of the areas of strategy, innovation, corporate culture and finance Comprehensive three-stage…
Advantech Capital and Vivo Capital have invested $15 million in Sinovac Research and Development Co., Ltd. (“Sinovac R&D”), a wholly owned subsidiary of Sinovac, to further the development of an inactivated vaccine against COVID-19 named CoronaVac.
Arctic Vision, a clinical stage biotechnology company focusing on the development and commercialization of innovative ophthalmology therapies in China and Asia, announced today the formation of its Scientific Advisory Board (SAB) comprised of three world-class ophthalmologists from China, the United States and the United Kingdom.
Novocure’s Optune has became the first innovative treatment for glioblastoma approved in China in over 15 years, the company said in a Wednesday press release, after it’s global phase 3 pivotal clinical study in newly diagnosed glioblastoma showed adding Optune to chemotherapy more than doubled the five-year overall survival rate.
Takeda has reported FY2019 revenue JPY 3,291 billion ($30.75M), up 57% in first full year following acquisition of Shire.
PharmaCyte Biotech said Monday that cGMP Validation, the company’s GMP consultant, is conducting its final audit of the manufacturing facility…